Cognito’s non-invasive medical device demonstrates durable effects on activities of daily living through OVERTURE open-label extension study. (N2.002)

To examine total, basic, and instrumental activities of daily living change from baseline, in mild and moderate Alzheimer’s disease (AD) participants in OVERTURE RCT (NCT03556280) and OVERTURE Open Label Extension (OLE).